Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TK3 for Quality of Life and Chemo Tolerance in Advanced Cancer
NCT03341286Phase 2Unknown
- Sponsor
- Centro Universitário Faculdade de Medicina do ABC
- Start
- Nov 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TK3 in cancer, sponsored by Centro Universitário Faculdade de Medicina do ABC. Status: unknown.
02
Drugs
TK3
03
Conditions
cancer
Beyond the preview
Go deeper on NCT03341286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03341286.